Details for New Drug Application (NDA): 211034
✉ Email this page to a colleague
The generic ingredient in ALBENDAZOLE is albendazole. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the albendazole profile page.
Summary for 211034
Tradename: | ALBENDAZOLE |
Applicant: | Dr Reddys |
Ingredient: | albendazole |
Patents: | 0 |
Pharmacology for NDA: 211034
Mechanism of Action | Cytochrome P450 1A Inducers |
Medical Subject Heading (MeSH) Categories for 211034
Suppliers and Packaging for NDA: 211034
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALBENDAZOLE | albendazole | TABLET;ORAL | 211034 | ANDA | Dr.Reddys Laboratories Inc | 43598-452 | 43598-452-02 | 2 TABLET, FILM COATED in 1 BOTTLE (43598-452-02) |
ALBENDAZOLE | albendazole | TABLET;ORAL | 211034 | ANDA | Dr.Reddys Laboratories Inc | 43598-452 | 43598-452-17 | 1 BLISTER PACK in 1 CARTON (43598-452-17) / 8 TABLET, FILM COATED in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Jan 26, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription